NCT01779700View on ClinicalTrials.gov

Fingolimod in Schizophrenia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Schizophrenia
Interventions
DRUG

Fingolimod

0.5mg each day of 8 week cycle

DRUG

placebo

1 tablet each day of 8 week cycle

Trial Locations (3)

46202

Center for NeuroImaging, Indianapolis

Prevention and Recovery Center, Indianapolis

46222

Larue D Carter Memorial Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT01779700 - Fingolimod in Schizophrenia Patients | Biotech Hunter | Biotech Hunter